Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Re-evaluation for Adolescents With Inflammatory Bowel Disease in Transition (TRANSIT) Trial

NCT02893670 is registered in ClinicalTrials.gov with Schneider Children's Medical Center, Israel as lead sponsor.

NCT NCT02893670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02893670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Re-evaluation for Adolescents With Inflammatory Bowel Disease in Transition (TRANSIT) Trial
Lead sponsor
Schneider Children's Medical Center, Israel
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
September 1, 2022
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease